Do type 2 diabetes patients without diabetic retinopathy or subjects with impaired fasting glucose have impaired colour vision? The Okubo Color Study Report

Diabetic Medicine

Volumn 28, Issue 7, 2011, Pages 865-871

  Shoji, T ^a,b   Sakurai, Y ^c   Sato, H ^a   Chihara, E ^d   Takeuchi, M ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Yukisada Hospital   (Japan)

^c Department of Preventive Medicine and Public Health ^*  (Japan)

^d Sensho kai Eye Institute   (Japan)

Author keywords

Acquired colour vision impairment; Diabetic neuropathy; Diabetic retinopathy

Indexed keywords

GLUCOSE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATARACT; COLOR VISION DEFECT; COLOR VISION TEST; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; EYE EXAMINATION; GLAUCOMA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; SMOKING; VENOUS BLOOD;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; COLOR VISION DEFECTS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 79958779806     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03290.x     Document Type: Article

References (30)

1. Zanen J. Dyschromatopsies retiniennes centrales acquises (Acquired central retinal dyschromatopsia). Ann Ocul (Paris) 1953; 186: 948-956.
2. Kinnear PR, Aspinall PA, Lakowski R. The diabetic eye and colour vision. Trans Ophthalmol Soc U K 1972; 92: 69-78.
3. Roy MS, Gunkel RD, Podgor MJ. Color vision defects in early diabetic retinopathy. Arch Ophthalmol 1986; 104: 225-228.
4. Green FD, Ghafour IM, Allan D, Barrie T, McClure E, Foulds WS. Colour vision of diabetics. Br J Ophthalmol 1985; 69: 533-536.
5. Trick GL, Burde RM, Gordon MO, Santiago JV, Kilo C. The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology 1988; 95: 693-698.
6. Muntoni S, Serra A, Mascia C, Songini M. Dyschromatopsia in diabetes mellitus and its relation to metabolic control. Diabetes Care 1982; 5: 375-378.
7. Lombrail P, Cathelineau G, Gervais P, Thibult N. Abnormal color vision and reliable self-monitoring of blood glucose. Diabetes Care 1984; 7: 318-321.
8. Melamud A, Hagstrom S, Traboulsi E. Color vision testing. Ophthalmic Genet 2004; 25: 159-187.
9. Gobba F. Color vision: a sensitive indicator of exposure to neurotoxins. Neurotoxicology 2000; 21: 857-862.
10. Ewing FM, Deary IJ, Strachan MW, Frier BM. Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations in vision. Endocr Rev 1998; 19: 462-476.
11. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30: 753-759.
12. Shoji T, Sakurai Y, Chihara E, Nishikawa S, Omae K. Reference intervals and discrimination values of the Lanthony desaturated D-15 panel test in young to middle-aged Japanese army officials: the Okubo Color Study Report1. Eye (Lond) 2009; 23: 1329-1335.
13. Shoji T, Sakurai Y, Sato H, Chihara E, Ishida M, Omae K. Serum low-density lipoprotein cholesterol level is strong risk factor for acquired color vision impairment in young to middle-aged Japanese men: the Okubo Color Study Report2. Atherosclerosis 2010; 210: 542-547.
14. Verriest G, Van Laethem J, Uvijls A. A new assessment of the normal ranges of the Farnsworth-Munsell 100-hue test scores. Am J Ophthalmol 1982; 93: 635-642.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: S62-S69.
16. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K et al. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007; 14: 155-158.
17. Third Report of the National Cholesterol Education Panel (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel or ATP III). NIH Publication No. 01-3305. May 2001.
18. Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL et al. The Lens Opacities Classification SystemIII. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 1993; 111: 831-836.
19. Taylor HR, West SK. A simple system for the clinical grading of lens opacities. Yan Ke Xue Bao 1988; 4: 14-18.
20. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 2003; 121: 519-526.
21. Gobba F, Cavalleri A. Color vision impairment in workers exposed to neurotoxic chemicals. Neurotoxicology 2003; 24: 693-702.
22. Fong DS, Ferris FL 3rd, Davis MD, Chew EY, Early Treatment Diabetic Retinopathy Study Research Group. Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no.24. Am J Ophthalmol 1999; 127: 137-141.
23. Karadeniz S, Kir N, Yilmaz MT, Ongor E, Dinccag N, Basar D et al. Alteration of visual function in impaired glucose tolerance. Eur J Ophthalmol 1996; 6: 59-62.
24. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
25. Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol 2008; 586: 4401-4408.
26. Wong TY, Liew G, Tapp RJ, Schmidt MI, Wang JJ, Mitchell P et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008; 371: 736-743.
27. Yamamoto S, Takeuchi S, Kamiyama M. The short wavelength-sensitive cone electroretinogram in diabetes: relationship to systemic factors. Doc Ophthalmol 1997; 94: 193-200.
28. Chihara E, Matsuoka T, Ogura Y, Matsumura M. Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy. Ophthalmology 1993; 100: 1147-1151.
29. Peng PH, Lin HS, Lin S. Nerve fibre layer thinning in patients with preclinical retinopathy. Can J Ophthalmol 2009; 44: 417-422.
30. Verma A, Rani PK, Raman R, Pal SS, Laxmi G, Gupta M et al. Is neuronal dysfunction an early sign of diabetic retinopathy? Microperimetry and spectral domain optical coherence tomography (SD-OCT) study in individuals with diabetes, but no diabetic retinopathy Eye (Lond) 2009; 23: 1824-1830.